Articles

RSS

Patheon Inc. , a leading provider of contract development and manufacturing services to the global pharmaceutical industry announced recently that it will be featuring its highly successful Performance Guarantee initiative for all new commercial customers at an upcoming industry conference. The initiative guarantees exceptional customer delivery performance without compromising product quality, at the same time ensuring reliable regulatory compliance. It is the only known guarantee in the pharmaceutical contract manufacturing industry.

Wes Wheeler, President and Chief Executive Officer of Patheon Inc. stated, "We have received an encouraging positive industry response to our Performance Guarantee initiative since we rolled it out earlier in the year. We continually work with our customers to improve our processes to eliminate waste, improve cost efficiencies, deliver product as promised and adhere to strict quality standards. Because of our success with these continuous improvement programs, we are willing to make financial commitments through our Performance Guarantee initiatives to ensure our customers obtain the exceptional service and product delivery that they have come to expect from us."

Representatives from Patheon will be available to discuss the company's Performance Guarantee at the upcoming CPhl Woldwide Conference in Madrid, Spain from October 13th through October 15th, 2009. The company will be exhibiting at Stand 8C10 through the duration of the conference. For those customers who cannot attend the conference, they may contact their Patheon sales representative.

About Patheon
Patheon Inc. is a leading provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, liquid- filled hard capsules and a variety of modified release technologies. For more information visit www.patheon.com

Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic™ programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API. Patheon's integrated development and manufacturing network of 11 facilities, and eight development centers across North America and Europe, strive to ensure that customer products can be launched with confidence anywhere in the world.

SOURCE: Patheon Inc.